Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
The Berkeley Catalyst Fund is a venture capital fund established to support early-stage startups in the life sciences sector. Founded by Dr. Ted Hou, Mr. Drew Lanza, and Dr. Laura Smoliar, the fund collaborates closely with UC Berkeley, Lawrence Berkeley National Laboratory, and UC San Francisco. This partnership enhances its ability to identify and nurture innovative companies in biotechnology and healthcare.
Located in the San Francisco Bay Area, the fund aims to create a thriving startup ecosystem. A unique aspect of the fund is its commitment to sharing a portion of its returns with the UC Berkeley Foundation, specifically to benefit the College of Chemistry. This initiative underscores the fund's dedication to fostering academic and entrepreneurial collaboration.
The Berkeley Catalyst Fund primarily invests in the life sciences sector, which encompasses therapeutics, diagnostics, and medical devices. Additionally, the fund has a broader investment scope that includes biotechnology, agriculture, cleantech—covering clean air, clean water, and energy storage—and sensors. The fund targets investments at the Seed and Series A stages, allowing it to engage with startups at critical points in their development.
By leveraging its connections with prestigious academic institutions, the fund aims to drive impactful advancements in these sectors. The focus on early-stage investments allows the fund to support innovative ideas and technologies that have the potential to transform healthcare and related fields.
The Berkeley Catalyst Fund has not publicly disclosed specific portfolio companies or notable exits. However, its investment strategy emphasizes sectors such as life sciences, biotechnology, and cleantech, which are critical areas for innovation and growth. The fund's collaboration with leading academic institutions positions it to identify promising startups within these sectors.
While detailed information about individual investments is not available, the fund's focus on therapeutics, diagnostics, and medical devices suggests a commitment to supporting companies that are developing solutions to pressing healthcare challenges.
Dr. Ted Hou - Founding Partner. Dr. Hou has a background in life sciences and has been instrumental in establishing the fund's focus on early-stage investments.
Mr. Drew Lanza - Founding Partner. Mr. Lanza brings extensive experience in venture capital and startup development, contributing to the fund's strategic direction.
Dr. Laura Smoliar - Founding Partner. Dr. Smoliar has a strong academic background and plays a key role in fostering collaborations with research institutions.
Startups interested in pitching to the Berkeley Catalyst Fund should submit their proposals through the fund's website. A well-structured pitch deck should include an overview of the business model, market opportunity, and team qualifications. Response times may vary, so founders should be prepared for potential follow-up discussions.
As of October 2023, the Berkeley Catalyst Fund has not publicly announced any recent investments, exits, or fund raises. The fund continues to focus on its mission of supporting early-stage startups in the life sciences sector through collaborations with academic institutions.
What are the investment criteria for the Berkeley Catalyst Fund?
The fund focuses on early-stage startups in the life sciences sector, including therapeutics, diagnostics, and medical devices. It also considers investments in biotechnology, agriculture, cleantech, and sensors.
How can startups apply or pitch to the fund?
Startups can pitch through the fund's website at berkeleycatalystfund.com. It is advisable to include a detailed business plan and information about the team and technology.
What makes the Berkeley Catalyst Fund different from other venture capital firms?
The fund's unique collaboration with UC Berkeley and other academic institutions provides access to cutting-edge research and development, enhancing its investment strategy.
What is the geographic focus of the fund?
The Berkeley Catalyst Fund primarily invests in startups located in North America, particularly those in the San Francisco Bay Area.
What is the fund size or check size for investments?
Specific quantitative metrics such as fund size or check sizes have not been disclosed, but the fund focuses on Seed and Series A investments.
What type of post-investment involvement does the fund have?
The fund typically engages with its portfolio companies through mentorship and support, leveraging its academic partnerships to provide resources and guidance.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.